K100538

Substantially Equivalent

TINA-QUANT FERRITIN GEN. 4

Applicant: Roche Diagnostics
Product code: DBF
Advisory panel: Immunology
Date received: 2010-02-25
Decision date: 2010-06-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.